Professional
Added to YB: 2024-09-27
Pitch date: 2024-09-24
ICCC [bullish]
ImmuCell Corporation
+70.14%
current return
Author Info
No bio for this author
Company Info
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.
Market Cap
$54.7M
Pitch Price
$3.65
Price Target
10.00 (+61%)
Dividend
N/A
EV/EBITDA
10.84
P/E
23.43
EV/Sales
2.32
Sector
Biotechnology
Category
turnaround
ImmuCell Corporation - $ICCC
ICCC: Animal health co. targeting dairy/beef cattle. First Defense product for calf scours prevention. Q2 revenue +82% YoY, production normalizing. Margins improving on 85% capacity, 8% price hike. Re-Tain FDA decision Q1'25 key catalyst. Undervalued at $10 PT (100-200% upside) on obscured financials, return to growth.
Read full article (8 min)